dalteparin has been researched along with Muscle Spasticity in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Muscle Spasticity: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a free interval) followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fasce, J | 1 |
| Calbacho, M | 1 |
| Oyarzun, M | 1 |
| Reinbach, K | 1 |
| Daza, A | 1 |
| García-Alix, A | 1 |
1 other study available for dalteparin and Muscle Spasticity
| Article | Year |
|---|---|
[Cerebral sinovenous thrombosis in a newborn with mutation of MTHFR C677T treated with enoxaparin].
Topics: Anticoagulants; Enoxaparin; Female; Genetic Markers; Homocystinuria; Homozygote; Humans; Infant, New | 2020 |